DE69620639D1 - MERCAPTOALKYLPEPTIDYL COMPOUNDS WITH AN IMIDAZOLE SUBSTITUENT AND THEIR USE AS INHIBITORS OF THE MATRIX METALLOPROTEINASES (MMP) AND / OR THE TUMOR NECROSIS FACTOR (TNF) - Google Patents
MERCAPTOALKYLPEPTIDYL COMPOUNDS WITH AN IMIDAZOLE SUBSTITUENT AND THEIR USE AS INHIBITORS OF THE MATRIX METALLOPROTEINASES (MMP) AND / OR THE TUMOR NECROSIS FACTOR (TNF)Info
- Publication number
- DE69620639D1 DE69620639D1 DE69620639T DE69620639T DE69620639D1 DE 69620639 D1 DE69620639 D1 DE 69620639D1 DE 69620639 T DE69620639 T DE 69620639T DE 69620639 T DE69620639 T DE 69620639T DE 69620639 D1 DE69620639 D1 DE 69620639D1
- Authority
- DE
- Germany
- Prior art keywords
- necrosis factor
- mmp
- tnf
- inhibitors
- tumor necrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Peptidyl compounds having an imidazole substituent have therapeutic utility via their inhibitory effect on metalloproteinases and tumour necrosis factor.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
PCT/GB1996/002892 WO1997019075A1 (en) | 1995-11-22 | 1996-11-22 | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69620639D1 true DE69620639D1 (en) | 2002-05-16 |
DE69620639T2 DE69620639T2 (en) | 2002-10-17 |
Family
ID=26308152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69620639T Expired - Fee Related DE69620639T2 (en) | 1995-11-22 | 1996-11-22 | MERCAPTOALKYLPEPTIDYL COMPOUNDS WITH AN IMIDAZOLE SUBSTITUENT AND THEIR USE AS INHIBITORS OF THE MATRIX METALLOPROTEINASES (MMP) AND / OR THE TUMOR NECROSIS FACTOR (TNF) |
Country Status (19)
Country | Link |
---|---|
US (1) | US6048841A (en) |
EP (1) | EP0874842B1 (en) |
JP (1) | JP2000500482A (en) |
KR (1) | KR19990067687A (en) |
CN (1) | CN1072667C (en) |
AT (1) | ATE215946T1 (en) |
AU (1) | AU711907B2 (en) |
BR (1) | BR9611636A (en) |
CA (1) | CA2229438C (en) |
CZ (1) | CZ291337B6 (en) |
DE (1) | DE69620639T2 (en) |
ES (1) | ES2172690T3 (en) |
HU (1) | HUP9904131A3 (en) |
IL (1) | IL123431A (en) |
MX (1) | MX9804052A (en) |
NO (1) | NO982290D0 (en) |
NZ (1) | NZ322565A (en) |
PL (1) | PL326710A1 (en) |
WO (1) | WO1997019075A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
RU2201931C2 (en) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Inhibitors of farnesyltransferase and methods of inhibition of farnesyltransferase |
CA2876779A1 (en) | 2000-05-12 | 2001-11-22 | Genzyme Corporation | Modulators of tnf-.alpha. signaling |
ES2208595T3 (en) | 2000-05-15 | 2004-06-16 | Darwin Discovery Limited | DERIVATIVES OF HYDROXAMIC ACID. |
SE0100903D0 (en) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (en) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0103710D0 (en) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
CN100503608C (en) * | 2002-01-07 | 2009-06-24 | 卫材R&D管理株式会社 | Deazapurines and uses thereof |
SE0202539D0 (en) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
ES2363914T3 (en) * | 2002-11-21 | 2011-08-19 | Genzyme Corporation | USE OF A DIAMIDE DERIVATIVE TO INHIBIT THE CHRONIC REJECTION OF A TRANSPLANT. |
US7217718B2 (en) * | 2002-11-21 | 2007-05-15 | Genzyme Corporation | Induction of immune tolerance |
US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (en) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0403086D0 (en) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (en) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
PL227790B1 (en) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Phosphonates of acetylene derivatives of betulin with antitumour effects, method for producing them and applications |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE150452T1 (en) * | 1992-04-07 | 1997-04-15 | British Biotech Pharm | COLLAGENASE INHIBITORS AND CYTOKINE ACTIVITY INHIBITORS CONTAINING HYDROXAMIC ACID |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
CN1193978A (en) * | 1994-10-05 | 1998-09-23 | 奇罗斯恩有限公司 | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
-
1996
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/en not_active Application Discontinuation
- 1996-11-22 PL PL96326710A patent/PL326710A1/en unknown
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
- 1996-11-22 ES ES96939208T patent/ES2172690T3/en not_active Expired - Lifetime
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 CN CN96198507A patent/CN1072667C/en not_active Expired - Fee Related
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/en unknown
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 DE DE69620639T patent/DE69620639T2/en not_active Expired - Fee Related
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/en unknown
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Application Discontinuation
- 1996-11-22 AT AT96939208T patent/ATE215946T1/en not_active IP Right Cessation
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/en not_active IP Right Cessation
- 1996-11-22 JP JP9519522A patent/JP2000500482A/en not_active Ceased
- 1996-11-22 NZ NZ322565A patent/NZ322565A/en unknown
-
1998
- 1998-05-20 NO NO982290A patent/NO982290D0/en not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL123431A0 (en) | 1998-09-24 |
NO982290L (en) | 1998-05-20 |
HUP9904131A3 (en) | 2002-04-29 |
NO982290D0 (en) | 1998-05-20 |
NZ322565A (en) | 1999-11-29 |
WO1997019075A1 (en) | 1997-05-29 |
AU711907B2 (en) | 1999-10-21 |
DE69620639T2 (en) | 2002-10-17 |
JP2000500482A (en) | 2000-01-18 |
CN1202895A (en) | 1998-12-23 |
MX9804052A (en) | 1998-09-30 |
ES2172690T3 (en) | 2002-10-01 |
CZ291337B6 (en) | 2003-02-12 |
KR19990067687A (en) | 1999-08-25 |
CN1072667C (en) | 2001-10-10 |
CA2229438A1 (en) | 1997-05-29 |
EP0874842B1 (en) | 2002-04-10 |
PL326710A1 (en) | 1998-10-26 |
CZ145598A3 (en) | 1998-08-12 |
US6048841A (en) | 2000-04-11 |
HUP9904131A2 (en) | 2000-06-28 |
AU7634396A (en) | 1997-06-11 |
CA2229438C (en) | 2006-01-17 |
ATE215946T1 (en) | 2002-04-15 |
BR9611636A (en) | 1999-12-28 |
IL123431A (en) | 2001-05-20 |
EP0874842A1 (en) | 1998-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69620639T2 (en) | MERCAPTOALKYLPEPTIDYL COMPOUNDS WITH AN IMIDAZOLE SUBSTITUENT AND THEIR USE AS INHIBITORS OF THE MATRIX METALLOPROTEINASES (MMP) AND / OR THE TUMOR NECROSIS FACTOR (TNF) | |
DE69631423D1 (en) | CHINOLONES AND THEIR THERAPEUTIC USE | |
BR9408025A (en) | Peptidyl compounds and their therapeutic use as metalloproteinase inhibitors | |
ES2133807T3 (en) | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS METALOPROTEASE INHIBITORS. | |
DE69722656D1 (en) | BICYCLIC ARYLCARBOXAMIDS AND THEIR THERAPEUTIC USE | |
DE69628019D1 (en) | CHINOLONES AND THEIR THERAPEUTIC USE | |
NO990543L (en) | Hydroxamic and carboxylic acid derivatives with MMP and TNF inhibitory activity | |
DE69835518D1 (en) | IMIDAZOLYL-CYCLIC ACETALE | |
DE1041982T1 (en) | INHIBITION OF p38 KINASE ACTIVITY BY SUBSTITUTED HETEROCYCLIC UREAS | |
ATE346600T1 (en) | INHIBITION OF P38 KINASE ACTIVITY BY THE USE OF ARYL AND HETEROARYL SUBSTITUTED UREAS | |
AU3738393A (en) | Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor | |
BR9805544C1 (en) | Use of a compound. | |
BG103832A (en) | Leptin as tumour cells proliferation inhibitor | |
ATE246184T1 (en) | QUINOLINES AND THEIR THERAPEUTIC USE | |
MX9802680A (en) | Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation. | |
MX9709361A (en) | 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds. | |
MX9706086A (en) | Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition. | |
ATE286892T1 (en) | HYDROXAM AND CARBOXYLIC ACID DERIVATIVES WITH MMP AND TNF INHIBITING ACTIVITY | |
ATE275955T1 (en) | USE OF PHOSPHOLAMBAN INHIBITORS TO INCREASE CORONARY BLOOD FLOW | |
FI972676A (en) | 4,4- (disubstituted) cyclohexane olonomers and the like |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |